How Emergent BioSolutions became the US go-to biodefense contractor

As it races to create a vaccine for the novel coronavirus, the Trump administration this month announced that one of its largest pandemic-related contracts would go to a little-known Gaithersburg biodefense company named Emergent BioSolutions. "Emergent's manufacturing capabilities will pave the way," Health and Human Services Secretary Alex Azar said in a statement. The $628 million ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.